2 unknown, 1 recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Unknown 1 |
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
Follow HB0025: new trials by email Literature Review of HB0025 trials Research Report on HB0025
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor HB0025, Pemetrexed, Paclitaxel - Advanced NSCLC, Advanced Endometrial Cancer | Phase 1 / Phase 2 | Recruiting | Huabo Biopharm Co., Ltd. | 282 | 2024-01-31 | 2025-01-23 |
| A Study of HB0025 Injection in Patients With Advanced Renal Cancer HB0025 - Renal Cancer | Phase 2 | Unknown | Huabo Biopharm Co., Ltd. | 100 | 2023-01-30 | 2024-01-24 |
| A Study of Injection HB0025 in Patients With Advanced Solid Tumors HB0025 - Tumor, Subjects | Phase 1 | Unknown | Huabo Biopharm Co., Ltd. | 154 | 2021-03-10 | 2022-06-01 |
Endometrial Neoplasms (1) · Kidney Neoplasms (1) · Neoplasms (1)
China (3) · United States (1)
Caicun Zhou, PhD. (1) · Dingwei Ye, MD/PHD (1) · Jundong Li, PhD. (1)